-
Notifications
You must be signed in to change notification settings - Fork 1
/
README.md.old
55 lines (27 loc) · 2.08 KB
/
README.md.old
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
# A Wiki on Epidemic Modeling
- Transmissibility and efficiency of various transmission mechanisms ([link](#Transmissibility-and-efficiency-of-various-transmission-mechanisms))
- Severity, stratified by key demographics ([link](#severity-stratified-by-key-demographics))
- Immune escape (from immunity generated by prior infection) ([link](#immune-escape-from-immunity-generated-by-prior-infection))
- Vaccine effectiveness and duration of effectiveness ([link](#vaccine-effectiveness-and-duration-of-effectiveness))
- Diagnostic sensitivity for active (acute) infection ([link](#diagnostic-sensitivity-for-active-acute-infection))
- Viral kinetics/epidemiological parameters (e.g., incubation period, latent period) ([link](#viral-kinetics-epidemiological-paraleters-eg-incubation-period-latent-period))
- Treatment escape ([link](#treatment-escape))
- Risk factors for infection and severity ([link](#risk-factors-for-infection-and-severity))
- Importation risk ([link](#importation-risk))
- Population mobility ([link](#population-mobility))
- Population level immunity (natural and vaccine derived) ([link](#population-level-immunity-natural-and-vaccine-derived))
- Other co-circulating pathogens of concern (i.e., if during a significant influenza season) ([link](#other-co-circulating-pathogens-of-concern-ie-if-during-a-significant-influenza-season))
- Resource / healthcare system capacity ([link](#resource--healthcare-system-capacity))
# Transmissibility and efficiency of various transmission mechanisms
# Severity, stratified by key demographics
# Immune escape (from immunity generated by prior infection)
# Vaccine effectiveness and duration of effectiveness
# Diagnostic sensitivity for active (acute) infection
# Viral kinetics/epidemiological parameters (e.g., incubation period, latent period)
# Treatment escape
# Risk factors for infection and severity
# Importation risk
# Population mobility
# Population level immunity (natural and vaccine derived)
# Other co-circulating pathogens of concern (i.e., if during a significant influenza season)
# Resource / healthcare system capacity